SUBSCRIBE
SUBSCRIBE
News   Business

Pernix Therapeutics, Inc. Reports Second Quarter 2012 Financial Results

August 14, 2012 | 
1 min read
THE WOODLANDS, Texas--(BUSINESS WIRE)--Pernix Therapeutics Holdings, Inc. (“Pernix” or the “Company”) (NYSE MKT: PTX), a specialty pharmaceutical company, today announced financial results for the quarter and six months ended June 30, 2012.
Earnings
MORE ON THIS TOPIC
Podcast
Second Half Milestones, KalVista’s Surprise Approval, Another RFK Jr. Lawsuit, More
July 9, 2025
 · 
1 min read
 · 
Heather McKenzie
People are attracted to a profitable business. Corporation, joint venture. Fundraising. Fair distribution of income among team members. Development of funds, budget use. Investment groups. Corruption
Radiopharmaceuticals
Actithera Raises $75.5M To Play in Sizzling Radiopharma Space
July 9, 2025
 · 
2 min read
 · 
Tristan Manalac
Solution Concept with Handshake on Chalkboard Background
Mergers & acquisitions
Concentra Snags Another Struggling Biotech as Cargo Accepts $200M Buyout
July 8, 2025
 · 
1 min read
 · 
Annalee Armstrong
Robot and human hand in retro collage style with halftone. Vector illustration, artificial intelligence concept.
Artificial intelligence
Roche’s Chugai Breaks Into Aging via Potential $1B+ Deal With AI Outfit Gero
July 7, 2025
 · 
2 min read
 · 
Dan Samorodnitsky